Barriers to Clinical Trial Enrollment: KCSG Survey–Based Perspectives of Medical Oncologists, Patients, and Their Caregivers
Cancer Research and Treatment · 15.07.2026 · 58 (3) · 720-727
DOI: 10.4143/crt.2025.523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Research and Treatment, erschienen am 15.07.2026. Verfasst von Chi Hoon Maeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology and Hematology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine…. Hauptthemen laut MEDLINE: Caregivers, Oncologists, Clinical Trials as Topic, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NIEHS NIH HHS, National Cancer Center, Korean Cancer Study Group.
Abstract (Originalsprache)
Purpose
Despite the critical role of clinical trials in advancing cancer treatment, patient enrollment remains challenging in South Korea. We aimed to identify key barriers to clinical trial participation from the perspectives of medical oncologists, patients, and caregivers.Materials and Methods Two web-based surveys were conducted in August 2022: one involving 100 Korean Cancer Study Group–affiliated medical oncologists, and another involving 100 cancer patients and 100 caregivers. Structured questionnaires were used to assess experiences, perceived barriers, and access to trial-related information. Focus group interviews (FGIs) were conducted with six patients and caregivers to explore qualitative insights in greater depth.
Results
Among oncologists, 98% had prior experience with clinical trials; the same proportion expressed willingness to refer patients to other institutions. However, 76% reported failed or abandoned referral attempts, primarily due to insufficient information on trial eligibility and enrollment status. Although 86% of patients and caregivers were aware of the clinical trial, only 23% had actual participation experience. Physician recommendations emerged as the most influential factor driving participation. Nonetheless, most reported difficulties in accessing reliable trial information, citing unfamiliarity with search tools, complex content, and absence of centralized platforms. The FGI findings supported these results, highlighting the importance of physician guidance and identifying limited access to information as major barriers to enrollment.
Conclusion
Despite positive attitudes, clinical trial participation remains constrained by fragmented referral systems and inaccessible information. Establishing a coordinated, interinstitutional referral platform and improving user-friendly information delivery may enhance enrollment and promote equitable access to cancer clinical trials in South Korea.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Oncology and Hematology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea.
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Oncology/ Hematology, Kyungpook National University Chilgok Hospital, Kyungpook National University School of Medicine, Daegu, Korea.
- Division of Oncology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
- Department of Hematology and Oncology, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Hwasun, Korea.
- Division of Hematology-Oncology, Department of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea. leptin72@gmail.com.
Förderung
- NIEHS NIH HHS
- National Cancer Center
- Korean Cancer Study Group
- Ministry of Health and Welfare
Zitieren
APA
Maeng, C. H., Park, I., Lee, I. H., An, H. J., Shim, H. J., & Lee, S. C. (2026). Barriers to Clinical Trial Enrollment: KCSG Survey–Based Perspectives of Medical Oncologists, Patients, and Their Caregivers. Cancer Research and Treatment, 58(3), 720-727. https://doi.org/10.4143/crt.2025.523
Vancouver
Maeng CH, Park I, Lee IH, An HJ, Shim HJ, Lee SC. Barriers to Clinical Trial Enrollment: KCSG Survey–Based Perspectives of Medical Oncologists, Patients, and Their Caregivers. Cancer Research and Treatment. 2026;58(3):720-727. doi:10.4143/crt.2025.523
BibTeX
@article{Maeng2026,
author = {Maeng, Chi Hoon and Park, Inkeun and Lee, In Hee and An, Ho Jung and Shim, Hyun Jeong and Lee, Sang-Cheol},
title = {Barriers to Clinical Trial Enrollment: KCSG Survey–Based Perspectives of Medical Oncologists, Patients, and Their Caregivers},
journal = {Cancer Research and Treatment},
year = {2026},
volume = {58},
number = {3},
pages = {720--727},
doi = {10.4143/crt.2025.523}
}
EUVIMED